HSD17B11 anticorps (AA 201-300) (AbBy Fluor® 350)
-
- Antigène Voir toutes HSD17B11 Anticorps
- HSD17B11 (Hydroxysteroid (17-Beta) Dehydrogenase 11 (HSD17B11))
-
Épitope
- AA 201-300
-
Reactivité
- Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HSD17B11 est conjugé à/à la AbBy Fluor® 350
-
Application
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Rat
- Homologie
- Human,Mouse,Cow,Sheep,Pig,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human Hsd17b11
- Isotype
- IgG
- Top Product
- Discover our top product HSD17B11 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- HSD17B11 (Hydroxysteroid (17-Beta) Dehydrogenase 11 (HSD17B11))
- Autre désignation
- HSD17B11 (HSD17B11 Produits)
- Synonymes
- anticorps 17BHSD11, anticorps DHRS8, anticorps PAN1B, anticorps RETSDR2, anticorps SDR16C2, anticorps Dhrs8, anticorps HSD17B13, anticorps MGC84756, anticorps HSD17B11, anticorps Pan1b, anticorps SDR2, anticorps retSDR2, anticorps 17-beta-HSD 11, anticorps 17-beta-HSD XI, anticorps 17bHSD11, anticorps 17betaHSD11, anticorps 17betaHSDXI, anticorps hydroxysteroid 17-beta dehydrogenase 11, anticorps hydroxysteroid (17-beta) dehydrogenase 11, anticorps hydroxysteroid (17-beta) dehydrogenase 11 L homeolog, anticorps estradiol 17-beta-dehydrogenase 11, anticorps HSD17B11, anticorps Hsd17b11, anticorps hsd17b11.L, anticorps hsd17b11, anticorps LOC100348005, anticorps LOC100520923
- Sujet
-
Synonyms: 17 beta HSD 11, 17 beta HSD XI, 17 BETA HSD11, 17 BETA HSDXI, 17 beta hydroxysteroid dehydrogenase 11, 17 beta hydroxysteroid dehydrogenase type XI, 17 beta hydroxysteroid dehydrogenase XI, 17-beta-HSD 11, 17-beta-HSD XI, 17-beta-hydroxysteroid dehydrogenase 11, 17-beta-hydroxysteroid dehydrogenase XI, 17betaHSD11, 17betaHSDXI, 17bHSD11, CTCL associated antigen HD CL 03, CTCL tumor antigen HD CL 03, CTCL-associated antigen HD-CL-03, Cutaneous T cell lymphoma associated antigen HD CL 03, Cutaneous T-cell lymphoma-associated antigen HD-CL-03, Dehydrogenase/reductase SDR family member 8, DHB11_HUMAN, DHRS8, Estradiol 17 beta dehydrogenase 11, Estradiol 17-beta-dehydrogenase 11, Hsd17b11, Hydroxysteroid (17 beta) dehydrogenase 11, PAN1B, Retinal short chain dehydrogenase/reductase 2, Retinal short-chain dehydrogenase/reductase 2, RETSDR2, SDR16C2, SDR2, Short chain dehydrogenase/reductase family 16C member 2, T cell lymphoma associated antigen HD CL 03, 17_-HSD11.
Background: Can convert androstan-3-alpha,17-beta-diol (3-alpha-diol) to androsterone in vitro, suggesting that it may participate in androgen metabolism during steroidogenesis. May act by metabolizing compounds that stimulate steroid synthesis and/or by generating metabolites that inhibit it. Has no activity toward DHEA (dehydroepiandrosterone), or A-dione (4-androste-3,17-dione), and only a slight activity toward testosterone to A-dione. Tumor-associated antigen in cutaneous T-cell lymphoma.
- ID gène
- 51170
- UniProt
- Q8NBQ5
-